Vazegepant hydrochloride (Vazegepant HCl) is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.
Molecular Weight:
675.3
Purity:
98.93%
CAS Number:
[1414976-20-7]
Formula:
C36H47ClN8O3
Target:
CGRP Receptor
T8682
* VAT and and shipping costs not included. Errors and price changes excepted